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A 69-year-old Caucasian man with a history of sclerosing
pancreatitis was followed in our nephrology department for
chronic kidney disease secondary to idiopathic retroperito-
neal fibrosis. During the past 10 years, he had displayed two
severe flares of retroperitoneal fibrosis, successfully treated by
steroids with partial recovery of renal function. His baseline
serum creatinine was 140 mmol/l.
On admission, the patient presented with acute-on-
chronic renal failure, a 4-kg weight loss, pelvic pain, urinary
frequency, and dysuria. Physical examination was unremark-
able except for a mildly enlarged prostate on digital rectal
examination. Serum creatinine was increased at 181 mmol/l
(MDRD 34ml/min per 1.73m2). C-reactive protein level
was 9mg/l. Antinuclear antibodies were positive without
specificity, as well as rheumatoid factor. Urine culture was
sterile and prostate-specific antigen level was normal. Renal
ultrasound showed right hydronephrosis. Trans-rectal ultra-
sound revealed a symmetric enlargement of the prostate
consistent with benign prostatic hyperplasia. Positron emis-
sion tomography with 18fluorodeoxyglucose showed a
significant uptake in the retroperitoneum and prostate
(Figure 1). A prostate biopsy was performed. Pathological
analysis revealed no malignancy but nodular hyperplasia
with fibrosis and dense inflammatory cell infiltration
composed of CD3þ T-lymphocytes and CD138þ polyclonal
plasma cells.
What underlying condition could explain both the retroperitoneal
fibrosis and the sclerosing prostatitis?
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Figure 1 |Positron emission tomography with
18fluorodeoxyglucose showing a significant
uptake in the retroperitoneum and prostate.
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The Diagnosis | IgG4-related systemic disease
The patient presented with acute-on-chronic renal failure
and nonbacterial prostatitis. He had experienced flares of
retroperitoneal fibrosis, and urinary symptoms attributed
to benign prostatic hyperplasia. However, the history of
sclerosing pancreatitis, the result of positron emission
tomography and pathological findings pointed to a single
disorder, characterized by lymphocyte and polyclonal plasma
cell tissue infiltration. Immunostaining of prostate biopsy
specimens with monoclonal antibodies directed against IgG4
revealed a dense IgG4þ plasma cell infiltrate, representing
more than 10 positive IgG4 plasma cells per high-power field
( 400, Figure 2). The measurement of serum IgG subclass
levels showed increased IgG4 (1.48mg/ml, normal range¼
0.01–1.35mg/ml). The diagnosis of IgG4-related systemic
disease (IgG4-RSD), with retroperitoneal fibrosis and
sclerosing prostatitis was retained. Prednisone (40mg/day)
was initiated. The patient promptly improved: he regained
weight and urinary symptoms resolved. Renal function
returned to baseline. Positron emission tomography and
serum IgG subclass levels normalized. Low-dose steroid
therapy (5mg/day) was maintained to prevent relapses.
Retroperitoneal fibrosis may be secondary to inflamma-
tory, infectious or malignant disorders. In our case, the
diagnosis of idiopathic retroperitoneal fibrosis was initially
retained because no underlying disease had been found.
Enlarged prostate and urinary symptoms were attributed to
benign prostatic hyperplasia, commonly observed in elderly
patients. However, the unexpected pathological findings made
us reconsider the diagnosis in favor of IgG4-RSD.
IgG4-RSD was firstly described in 2003 in Japan as an
overlapping syndrome with autoimmune pancreatitis.1,2
IgG4-RSD remains widely underdiagnosed in Western
countries. Many conditions fall within its spectrum including
retroperitoneal fibrosis.1 IgG4-related sclerosing prostatitis
has been rarely reported.3 The present case underscores the
importance for physicians to reconsider the diagnosis of
‘idiopathic’ retroperitoneal fibrosis in the light of IgG4-RSD,
particularly when associated with systemic manifestations.
Elevated levels of serum IgG4 (41.35mg/ml) and presence of
abundant infiltration by IgG4-positive plasma cells are the
diagnosis corner stone.2 Steroids are the mainstay of the
treatment.4 The initial dose is usually 0.6mg/kg/day for
2–4 weeks, then gradually tapered to a maintenance dose
of 2.5–5mg/day.4 Short-term response is favorable. Relapses
occur in approximately one-third of patients and require
steroid re-administration.4 Immunomodulatory drugs, such
as azathioprine and mycophenolate mofetil, have been used
to obtain sustained remission in case of insufficient response
to steroids.4 Rituximab has also been found to be effective in
small series. However, patients should be monitored carefully
as long-term outcome remains unknown.4
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Figure 2 | Immunohistochemical staining for IgG4 subclass (original
magnification,  400). Lymphocytes and plasma cells infiltrate the prostate tissue
with more than 10 positive IgG4 plasma cells per high-power field.
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